Integrated Diagnostics Holdings plc (LON:IDHC – Get Free Report) shares reached a new 52-week low during mid-day trading on Thursday. The company traded as low as GBX 0.45 and last traded at GBX 0.46, with a volume of 20,480 shares. The stock had previously closed at GBX 0.46.
Integrated Diagnostics Price Performance
The company has a debt-to-equity ratio of 42.91, a quick ratio of 0.75 and a current ratio of 1.67. The firm has a market capitalization of £2.67 million, a PE ratio of 0.00, a price-to-earnings-growth ratio of 7.65 and a beta of 0.44. The business’s 50 day moving average is GBX 0.52 and its two-hundred day moving average is GBX 0.57.
Integrated Diagnostics Company Profile
IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.
Featured Articles
- Five stocks we like better than Integrated Diagnostics
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
- Constellation Energy’s Nuclear Expansion Gets a $5 Billion Opening, Not a Guarantee
- Plugging In: Vertiv Cashes In On AI Demand
Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg){kind=logo}
